This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

States look to block Sandoz settlement in generic drug litigation

( May 9, 2025, 22:31 GMT | Official Statement) -- MLex Summary: A group of US states, territories and the District of Columbia asked a US judge to allow them to intervene in a private suit accusing Sandoz of engaging in a conspiracy to fix the prices of generic pharmaceuticals, seeking to oppose a settlement with end-payers. “The settlement implicates the states’ ever-present interest in obtaining a fair recovery for consumers harmed by Sandoz’s anticompetitive conduct, which the settlement and allocation plan, especially taken together, do not provide. The settlement also implicates additional sovereign interests the states have relating to the claims against Sandoz that states have been vigorously litigating on behalf of consumers for nearly a decade and which are currently in the District of Connecticut,” they said.See attached file....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Documents

Related Sections